Molecular Devices
Molecular Devices is a life science instrumentation and software company that provides analytical systems, automation platforms, and informatics tools for biological research and screening workflows in academic, biopharma, and industrial laboratories.
- Microplate readers and detection systems for absorbance, fluorescence, luminescence, and multimode assays (laboratory instrumentation)
- High-content imaging and cellular analysis platforms for phenotypic screening and cell-based assays (bioimaging and analytics)
- Biologics discovery and screening systems for antibodies, cell lines, and other biologic modalities (drug discovery tools)
- Automation solutions, including integrated workcells and liquid handling platforms for assay miniaturization and throughput scaling (laboratory automation)
- Data analysis and acquisition software for instrument control, image analysis, and quantitative assay readouts (scientific informatics)
More About Molecular Devices
Molecular Devices provides instrumentation, automation, and software that integrate into enterprise and institutional life science environments such as pharmaceutical and biotechnology Research and Development (R&D) labs, contract research organizations, core facilities, and academic research centers. Its platforms are used across assay development, primary and secondary screening, hit-to-lead workflows, and routine quantitative biological measurements, with deployment models that range from stand-alone benchtop systems to fully integrated, automated screening lines.
The company’s microplate readers (laboratory instrumentation) support multiple detection modes, including absorbance, fluorescence, luminescence, time-resolved fluorescence, and fluorescence polarization. These systems are commonly configured in 96- to 1536-well formats and are compatible with standard microplate interfaces and laboratory information workflows. They typically integrate via USB or Ethernet connectivity and export structured data formats for downstream analysis in the vendor’s own software or third-party analytics environments.
In cellular imaging, Molecular Devices offers high-content imaging platforms (bioimaging and analytics) that combine automated microscopy with plate handling and image analysis software. These systems support widefield and confocal imaging modalities, multi-channel fluorescence, and time-lapse acquisition for live or fixed cells. Image analysis workflows commonly rely on segmentation, feature extraction, and classification pipelines, configurable through graphical interfaces or scripted pipelines where provided, to quantify morphology, intensity, and phenotypic changes at the single-cell and population level.
For biologics discovery, Molecular Devices provides systems (drug discovery tools) that support antibody screening, cell line development, and other biologic workflows. These platforms are used to evaluate expression, binding, and functional response in microplate or imaging-based assays. They are often integrated with automation hardware, including plate handlers and robotic arms, to support higher-throughput screening and reproducible assay runs under defined environmental and timing conditions.
The company also supplies automation platforms (laboratory automation) that integrate microplate readers, incubators, liquid handlers, and storage devices into cohesive workcells. These systems rely on standardized plate formats, scheduling software, and device drivers to coordinate multi-step assay protocols, reduce manual handling, and maintain consistent incubation and readout conditions. Integration with laboratory information management and electronic lab notebook systems is typically achieved via file-based exchange, APIs when available, or instrument middleware.
Across these hardware offerings, Molecular Devices provides data acquisition and analysis software (scientific informatics) that manages instrument control, plate layout design, assay setup, and result quantification. The software usually supports curve fitting, normalization, quality control metrics, and reporting functions aligned with common assay formats such as dose-response, EC50/IC50 determination, and cell viability assays. In enterprise settings, these tools help standardize data output across multiple instruments and sites, enabling aggregated analysis and reproducible workflows for discovery and screening programs.